Pregnancy outcome following fetal reduction from dichorionic twins to singleton gestation.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
03 Jul 2020
Historique:
received: 24 12 2019
accepted: 24 06 2020
entrez: 5 7 2020
pubmed: 6 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

There are still some controversies regarding the risks and benefits of fetal reduction from twins to singletons. We aimed to evaluate if fetal reduction from twins to singleton improves pregnancy outcome. Retrospective analysis of all dichorionic-diamniotic twin pregnancies, who underwent fetal reduction. Pregnancy outcome was compared to ongoing, non-reduced, dichorionic-diamniotic gestations. Primary outcome was preterm birth prior to 37 gestational weeks. Secondary outcomes included: preterm birth prior to 34 gestational weeks, gestational age at delivery, birthweight, small for gestational age, hypertensive disorders, gestational diabetes and stillbirth. Ninety-eight reduced pregnancies were compared with 222 ongoing twins. Preterm birth < 37 gestational weeks (39.6% vs. 57.6%, p < 0.001) was significantly lower in the reduced group compared to the ongoing twins' group. A multivariate analysis, controlling for parity and mode of conception, demonstrated that fetal reduction independently and significantly reduced the risk for prematurity (aOR 0.495, 95% CI -0.299-0.819). Subgroup analysis, similarly adjusted demonstrated lower rates of preterm delivery in those undergoing elective reduction (aOR = 0.206, 95% CI 0.065-0.651), reduction due to fetal anomalies (aOR = 0.522, 95% CI 0.295-0.926) and 1st trimester reduction (aOR = 0.297, 95% Cl 0.131-0.674) all compared to ongoing twins. A Kaplan-Meier survival curve showed a significant proportion of non-delivered women at each gestational week in the reduced group compared to non-reduced twins, after 29 gestational weeks. Fetal reduction from twins to singleton reduces the risk of preterm birth < 37 gestational weeks, but not for more severe maternal and perinatal complications.

Sections du résumé

BACKGROUND BACKGROUND
There are still some controversies regarding the risks and benefits of fetal reduction from twins to singletons. We aimed to evaluate if fetal reduction from twins to singleton improves pregnancy outcome.
METHODS METHODS
Retrospective analysis of all dichorionic-diamniotic twin pregnancies, who underwent fetal reduction. Pregnancy outcome was compared to ongoing, non-reduced, dichorionic-diamniotic gestations. Primary outcome was preterm birth prior to 37 gestational weeks. Secondary outcomes included: preterm birth prior to 34 gestational weeks, gestational age at delivery, birthweight, small for gestational age, hypertensive disorders, gestational diabetes and stillbirth.
RESULTS RESULTS
Ninety-eight reduced pregnancies were compared with 222 ongoing twins. Preterm birth < 37 gestational weeks (39.6% vs. 57.6%, p < 0.001) was significantly lower in the reduced group compared to the ongoing twins' group. A multivariate analysis, controlling for parity and mode of conception, demonstrated that fetal reduction independently and significantly reduced the risk for prematurity (aOR 0.495, 95% CI -0.299-0.819). Subgroup analysis, similarly adjusted demonstrated lower rates of preterm delivery in those undergoing elective reduction (aOR = 0.206, 95% CI 0.065-0.651), reduction due to fetal anomalies (aOR = 0.522, 95% CI 0.295-0.926) and 1st trimester reduction (aOR = 0.297, 95% Cl 0.131-0.674) all compared to ongoing twins. A Kaplan-Meier survival curve showed a significant proportion of non-delivered women at each gestational week in the reduced group compared to non-reduced twins, after 29 gestational weeks.
CONCLUSIONS CONCLUSIONS
Fetal reduction from twins to singleton reduces the risk of preterm birth < 37 gestational weeks, but not for more severe maternal and perinatal complications.

Identifiants

pubmed: 32620088
doi: 10.1186/s12884-020-03076-7
pii: 10.1186/s12884-020-03076-7
pmc: PMC7333296
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389

Références

Fertil Steril. 2004 May;81(5):1420-2
pubmed: 15136118
Am J Obstet Gynecol. 2015 Oct;213(4):580.e1-5
pubmed: 26071922
Obstet Gynecol. 2004 Jul;104(1):102-9
pubmed: 15229007
Hum Reprod. 2015 Aug;30(8):1807-12
pubmed: 26093542
Obstet Gynecol. 2014 May;123(5):1118-32
pubmed: 24785876
Obstet Gynecol. 2019 Jan;133(1):e1-e25
pubmed: 30575675
Isr Med Assoc J. 2005 May;7(5):311-4
pubmed: 15909464
Am J Obstet Gynecol. 2019 Sep;221(3):253.e1-253.e8
pubmed: 30995460
Fertil Steril. 2015 Feb;103(2):428-32
pubmed: 25455874
J Matern Fetal Neonatal Med. 2003 Apr;13(4):218-23
pubmed: 12854920
Obstet Gynecol. 2009 Mar;113(3):748-61
pubmed: 19300347
Obstet Gynecol. 2018 Feb;131(2):e49-e64
pubmed: 29370047
J Matern Fetal Neonatal Med. 2011 Nov;24(11):1362-6
pubmed: 21247231
Pediatr Res. 2002 Nov;52(5):671-81
pubmed: 12409512
Hum Reprod. 1998 Aug;13(8):2301-4
pubmed: 9756315
Obstet Gynecol. 2016 Jan;127(1):49-58
pubmed: 26646133
Obstet Gynecol. 2013 Feb;121(2 Pt 1):405-10
pubmed: 23344306
Fetal Diagn Ther. 2014;35(2):69-82
pubmed: 24525884

Auteurs

Gal Greenberg (G)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ron Bardin (R)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Shir Danieli-Gruber (S)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Kinneret Tenenbaum-Gavish (K)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anat Shmueli (A)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eyal Krispin (E)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Galia Oron (G)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Arnon Wiznitzer (A)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eran Hadar (E)

Helen Schneider's Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, 4941492, Petach-Tikva, Israel. eranh42@gmail.com.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. eranh42@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH